Prognostic Comparison of the Estimations of Renal Function in Patients With Acute Heart Failure

  • Cheng Yu-Lun
    Department of Medicine, Taipei Veterans General Hospital Department of Medicine, National Yang-Ming University Institute of Public Health, National Yang-Ming University
  • Sung Shih-Hsien
    Department of Medicine, Taipei Veterans General Hospital Department of Medicine, National Yang-Ming University Institute of Public Health, National Yang-Ming University
  • Cheng Hao-Min
    Department of Medical Education, Taipei Veterans General Hospital Cardiovascular Research Center, National Yang-Ming University Department of Medicine, National Yang-Ming University
  • Huang Jui-Tzu
    Department of Medicine, National Yang-Ming University
  • Guo Chao-Yu
    Institute of Public Health, National Yang-Ming University
  • Hsu Pai-Feng
    Healthcare and Management Center, Taipei Veterans General Hospital Department of Medicine, National Yang-Ming University Institute of Public Health, National Yang-Ming University
  • Yu Wen-Chung
    Department of Medicine, Taipei Veterans General Hospital Cardiovascular Research Center, National Yang-Ming University Department of Medicine, National Yang-Ming University
  • Chen Chen-Huan
    Department of Medical Education, Taipei Veterans General Hospital Cardiovascular Research Center, National Yang-Ming University Department of Medicine, National Yang-Ming University Institute of Public Health, National Yang-Ming University

この論文をさがす

抄録

<p>Background: The prognostic significance of the eGFR calculated by either the four-level Race Chronic Kidney Disease-Epidemiology Collaboration study equation (CKD-EPI4R) or the Chinese-modified Modification of Diet in Renal Disease equation (cMDRD) has not been compared in Asian populations with acute heart failure (AHF).</p><p>Methods and Results:A total of 3,044 patients hospitalized for AHF were enrolled. The National Death Registry was linked to identify deaths within a 5-year follow-up. Net reclassification improvement (NRI) was calculated to compare the prognostic value of either eGFR equation. During a median follow-up of 23.3 months, 1,424 (47%) patients died. Both eGFRcMDRDand eGFRCKD-EPI4Rwere independently predictive of death in the total study population (hazard ratio and 95% confidence intervals per 1-SD: 0.76, 0.71–0.81 and 0.74, 0.70–0.79, respectively), and in the subgroups of either reduced (HFrEF) or preserved (HFpEF) ejection fraction, after accounting for important confounders. With reference to eGFRcMDRD, eGFRCKD-EPI4Rmay improve the NRI by 2.0% (0.8–3.2%) for the prediction of death. The prognostic value of the CKD stages categorized by eGFRCKD-EPI4Rsignificantly outperformed eGFRcMDRDwith a categorical NRI of 9.5% (4.7–14.3%) in the total study population, 11.5% in HFrEF, and 8.3% in HFpEF.</p><p>Conclusions:Both eGFRcMDRDand eGFRCKD-EPI4Rwere independently associated with long-term survival in patients with AHF. However, the CKD stages derived from eGFRCKD-EPI4Rimproved the risk stratification of death, compared with eGFRcMDRD.</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 83 (4), 767-774, 2019-03-25

    一般社団法人 日本循環器学会

参考文献 (30)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ